Evidence map›Paper›PMID 35187497›Full record

ArticleCritical care explorations2022

Multicenter Retrospective Review of Ketamine Use in the ICU.

Christine M Groth, Christopher A Droege, Kathryn A Connor, Kimberly Kaukeinen, Nicole M Acquisto, Sai Ho J Chui, Michaelia D Cucci, Deepali Dixit, Alexander H Flannery, Kyle A Gustafson and 10 more

Abstract read
In one paragraph

Article in Critical care explorations, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Ketamine sedation in the intensive care unit: a survey of Canadian intensivists.Canadian journal of anaesthesia = Journal canadien d'anesthesie · 2024
    Trial
  3. Sedation and analgesia strategies in the neuro intensive care unit.World journal of critical care medicine · 2025
    Review
  4. Review
  5. Review
  6. Observational
  7. Article
  8. Article
  9. Review
  10. Ketamine-based Sedation Use in Mechanically Ventilated Critically Ill Patients with COVID-19: A Multicenter Cohort Study.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Christine M GrothUniversity of Rochester Medical Center, Departments of Pharmacy, Biostatistics and Computational Biology, and Emergency Medicine, Rochester, NY.
Christopher A DroegeUC Health-University of Cincinnati Medical Center, Department of Pharmacy Services, Cincinnati, OH.
Kathryn A ConnorSt. John Fisher College-Wegmans School of Pharmacy, Department of Pharmacy Practice and Administration, Rochester, NY.
Kimberly KaukeinenUniversity of Rochester Medical Center, Departments of Pharmacy, Biostatistics and Computational Biology, and Emergency Medicine, Rochester, NY.
Nicole M AcquistoUniversity of Rochester Medical Center, Departments of Pharmacy, Biostatistics and Computational Biology, and Emergency Medicine, Rochester, NY.
Sai Ho J ChuiUniversity of Maryland Medical Center, Department of Pharmacy, Baltimore, MD.
Michaelia D CucciCleveland Clinic Akron General, Department of Pharmacy, Akron, OH.
Deepali DixitErnest Mario School of PharmacyRutgers, The State University of New Jersey and Robert Wood Johnson University Hospital, New Brunswick, NJ.
Alexander H FlanneryUniversity of Kentucky College of Pharmacy, Department of Pharmacy Practice and Science, Lexington, KY.
Kyle A GustafsonNortheastern Ohio Medical University, Department of Pharmacy Practice, Rootstown, OH.
Nina E GlassRutgers, New Jersey Medical School, Department of Surgery, Newark, NJ.
Helen HorngUniversity Hospital of New Jersey, Pharmaceutical Services, Newark, NJ.
Mojdeh S HeavnerUniversity of Maryland School of Pharmacy, Department of Pharmacy Practice and Science, Baltimore, MD.
Justin KinneyLoma Linda University School of Pharmacy, Department of Pharmacy Practice, Loma Linda, CA.
Rachel M KruerIndiana University Health, Adult Academic Health Center, Department of Pharmacy, Indianapolis, IN.
William J PeppardFroedtert & the Medical College of Wisconsin, Department of Pharmacy and Department of Surgery, Division of Trauma and Acute Care Surgery, Milwaukee, WI.
Preeyaporn SarangarmUniversity of New Mexico Hospitals, Department of Pharmacy, Albuquerque, NM.
Andrea SikoraUniversity of Georgia College of Pharmacy, Department of Clinical and Administrative Pharmacy/Augusta University Medical Center, Department of Pharmacy, Augusta, GA.
Velliyur VisweshRoseman University of Health Sciences, Department of Pharmacy Practice, Henderson, NV.
Brian L ErstadUniversity of Arizona College of Pharmacy, Department of Pharmacy Practice & Science, Tucson, AZ.

Funding

Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE)UL1TR002378 · NCATS · EMORY UNIVERSITY · PI Andres J Garcia, Elizabeth O. Ofili · 2017 to 2026
$92.1M
Institutional Career Development CoreKL2TR002381 · NCATS · EMORY UNIVERSITY · PI HENRY M BLUMBERG, Anandi Nayan Sheth · 2017 to 2026
$14.1M
Neuro HPA Project 1U54AG062334 · NIA · EMORY UNIVERSITY · PI Ighovwerha Ofotokun · 2018 to 2026
$12.2M
Classical and Alternative Renin-Angiotensin System Dysregulation in Sepsis-Associated AKI: A Reverse Translation ApproachK23DK128562 · NIDDK · UNIVERSITY OF KENTUCKY · PI FLANNERY, ALEXANDER H · 2022 to 2024
$415k
NCATS NIH HHS KL2 TR002381NCATS NIH HHS UL1 TR002378NIA NIH HHS U54 AG062334
6 · The paper itself

Abstract

The response of ICU patients to continuously infused ketamine when it is used for analgesia and/or sedation remains poorly established.

objectivesTo describe continuous infusion (CI) ketamine use in critically ill patients, including indications, dose and duration, adverse effects, patient outcomes, time in goal pain/sedation score range, exposure to analgesics/sedatives, and delirium. DESIGN SETTING AND

participantsMulticenter, retrospective, observational study from twenty-five diverse institutions in the United States. Patients receiving CI ketamine between January 2014 and December 2017. MAIN OUTCOMES AND MEASURES: Chart review evaluating institutional and patient demographics, ketamine indication, dose, administration, and adverse effects. Pain/sedation scores, cumulative doses of sedatives and analgesics, and delirium screenings in the 24 hours prior to ketamine were compared with those at 0-24 hours and 25-48 hours after.

resultsA total of 390 patients were included (median age, 54.5 yr; interquartile range, 39-65 yr; 61% males). Primary ICU types were medical (35.3%), surgical (23.3%), and trauma (17.7%). Most common indications were analgesia/sedation ( CONCLUSIONS AND RELEVANCE: There is variability in the use of CI ketamine. Hemodynamic instability was the most common adverse effect. In the 48 hours after ketamine initiation compared with the 24 hours prior, proportion of time spent in goal pain/sedation score range increased and exposure to other analgesics/sedatives decreased.

Indexed as

analgesiadeliriumdrug-related side effects and adverse reactionshypnotics and sedativesintensive care unitsketamine

Identifiers

PMID35187497
PMCPMC8843366

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.